1
|
Szabados M, Csákó Z, Kakucs R, Középesy S, Czégény Z, Ciglova K, Dvorakova D, Szigeti T. Phthalate and DINCH metabolites in the urine of Hungarian schoolchildren: Cumulative risk assessment and exposure determinants. ENVIRONMENTAL RESEARCH 2024; 262:119834. [PMID: 39182753 DOI: 10.1016/j.envres.2024.119834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 07/30/2024] [Accepted: 08/21/2024] [Indexed: 08/27/2024]
Abstract
A human biomonitoring study was conducted to assess the exposure of Hungarian children aged 8-11 years to ten phthalate esters (PEs) and DINCH between 2017 and 2018. In addition to collecting urine samples from 262 participants, a questionnaire was completed by the parents or legal guardians to identify potential determinants of exposure. The highest geometric mean concentration was observed for MiBP, followed by MBP, cx- MEHP, OH-MEHP and MEP. Three out of the four DINCH metabolites were detected in more than 90% of the samples. The comparison of the urinary concentrations measured in this study with those observed in the DEMOCOPHES study revealed a significant decreasing trend in all PE metabolites investigated in both studies between 2011/2012 and 2017/2018. Different approaches were used to assess the health risks associated with the exposure to PEs and DINCH. Our results highlighted that the hazard index (HI) values were higher than 1 in 17.6% of the children when the human biomonitoring guidance values were applied. In contrast, less than 3% of the children had HI values exceeding 1 when other sources of reference values were used. By applying a safety factor of 10 for the risk assessment, 17.6-91.6% of the children were characterized by HI values higher than 0.1, indicating the need for risk reduction measures. Overall, DnBP, DiBP and DEHP were identified as the main drivers of the mixture risk. Although PEs and DINCH are ubiquitous contaminants, there are still inconsistencies and gaps in our understanding of the determinants of exposure. The results of the multivariate regression analysis showed significant associations between PE or DINCH metabolite concentrations and certain individual characteristics, use of personal care products, home and school environment and food and beverages consumption 24 h prior to sample collection.
Collapse
Affiliation(s)
- Máté Szabados
- National Center for Public Health and Pharmacy, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Zsófia Csákó
- National Center for Public Health and Pharmacy, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Réka Kakucs
- National Center for Public Health and Pharmacy, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Szilvia Középesy
- National Center for Public Health and Pharmacy, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Zsuzsanna Czégény
- HUN-REN Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, Magyar Tudósok Körútja 2, 1117, Budapest, Hungary
| | - Kateřina Ciglova
- University of Chemistry and Technology, Prague, Faculty of Food and Biochemical Technology, Department of Food Analysis and Nutrition, Technicka 5, 166 28, Prague, Czech Republic
| | - Darina Dvorakova
- University of Chemistry and Technology, Prague, Faculty of Food and Biochemical Technology, Department of Food Analysis and Nutrition, Technicka 5, 166 28, Prague, Czech Republic
| | - Tamás Szigeti
- National Center for Public Health and Pharmacy, Albert Flórián út 2-6., 1097, Budapest, Hungary.
| |
Collapse
|
2
|
Hopf NB, De Luca HP, Borgatta M, Koch HM, Pälmke C, Benedetti M, Berthet A, Reale E. Human skin absorption of three phthalates. Toxicol Lett 2024; 398:38-48. [PMID: 38880306 DOI: 10.1016/j.toxlet.2024.05.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 05/01/2024] [Accepted: 05/30/2024] [Indexed: 06/18/2024]
Abstract
Population studies reveal widespread exposure to phthalates. Understanding their absorption, distribution, metabolism, and excretion is vital to reduce exposure. However, data on skin absorption remain limited. We thus aim to characterize the skin permeation of three phthalates in a mixture, neat or in emulsion; di(2-ethylhexyl) phthalate (d4-DEHP), dibutyl phthalate (d4-DBP), and diethyl phthalate (d4-DEP), by comparing in vitro human skin (800 µm) permeation (24 hours) results using flow-through diffusion cells with urine results obtained from volunteers exposed to the same mixture applied to a forearm (40 cm2). Metabolites were analyzed in receptor fluids and urine. Phthalates crossed the skin barrier and metabolized into monoesters before elimination. Increased permeation was observed for phthalates in emulsion compared to neat substances, with polyethylene glycol (PEG) in the receptor fluid enhancing emulsion permeation, but not affecting neat substances. In vitro results mirrored in vivo findings: DEP showed rapid permeation (J: ∼2 ug/cm2/h) and urinary excretion peaking at six hours post-application, whereas DBP exhibited slower kinetics (J: ∼0.1 ug/cm2/h), with a urinary peak at 15-17 hours post-application. DEHP had minimal permeation (J: ∼0.0002 ug/cm2/h) with no observable urinary peak. These findings underscore the importance of comprehending phthalate skin absorption for effective exposure mitigation strategies.
Collapse
Affiliation(s)
- Nancy B Hopf
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Basel.
| | - Hélène P De Luca
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Basel
| | - Myriam Borgatta
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Basel
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany
| | - Claudia Pälmke
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany
| | - Manon Benedetti
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland
| | - Aurélie Berthet
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Basel
| | - Elena Reale
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Route de la Corniche 2, Epalinges, Lausanne 1066, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Basel
| |
Collapse
|
3
|
Gerofke A, Lange R, Vogel N, Schmidt P, Weber T, David M, Frederiksen H, Baken K, Govarts E, Gilles L, Martin LR, Martinsone Ž, Santonen T, Schoeters G, Scheringer M, Domínguez-Romero E, López ME, Calvo AC, Koch HM, Apel P, Kolossa-Gehring M. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU. Int J Hyg Environ Health 2024; 259:114378. [PMID: 38631089 DOI: 10.1016/j.ijheh.2024.114378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 04/07/2024] [Accepted: 04/07/2024] [Indexed: 04/19/2024]
Abstract
Phthalates and the substitute plasticizer DINCH belong to the first group of priority substances investigated by the European Human Biomonitoring Initiative (HBM4EU) to answer policy-relevant questions and safeguard an efficient science-to-policy transfer of results. Human internal exposure levels were assessed using two data sets from all European regions and Israel. The first collated existing human biomonitoring (HBM) data (2005-2019). The second consisted of new data generated in the harmonized "HBM4EU Aligned Studies" (2014-2021) on children and teenagers for the ten most relevant phthalates and DINCH, accompanied by a quality assurance/quality control (QA/QC) program for 17 urinary exposure biomarkers. Exposures differed between countries, European regions, age groups and educational levels. Toxicologically derived Human biomonitoring guidance values (HBM-GVs) were exceeded in up to 5% of the participants of the HBM4EU Aligned Studies. A mixture risk assessment (MRA) including five reprotoxic phthalates (DEHP, DnBP, DiBP, BBzP, DiNP) revealed that for about 17% of the children and teenagers, health risks cannot be excluded. Concern about male reproductive health emphasized the need to include other anti-androgenic substances for MRA. Contaminated food and the use of personal care products were identified as relevant exposure determinants paving the way for new regulatory measures. Time trend analyses verified the efficacy of regulations: especially for the highly regulated phthalates exposure dropped significantly, while levels of the substitutes DINCH and DEHTP increased. The HBM4EU e-waste study, however, suggests that workers involved in e-waste management may be exposed to higher levels of restricted phthalates. Exposure-effect association studies indicated the relevance of a range of endpoints. A set of HBM indicators was derived to facilitate and accelerate science-to-policy transfer. Result indicators allow different groups and regions to be easily compared. Impact indicators allow health risks to be directly interpreted. The presented results enable successful science-to-policy transfer and support timely and targeted policy measures.
Collapse
Affiliation(s)
- Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
| | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Nina Vogel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Till Weber
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100, Copenhagen, Denmark; International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital-Rigshospitalet, 2100, Copenhagen, Denmark
| | - Kirsten Baken
- Brabant Advies, Brabantlaan 3, 5216 TV 's, Hertogenbosch, the Netherlands
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Žanna Martinsone
- Institute of Occupational Safety and Environmental Health, Rīga Stradiņš University, Dzirciema 16, LV-1007, Riga, Latvia
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032, Tyoterveyslaitos, Finland
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; University of Antwerp, Toxicological Center, Universiteitsplein 1, 2610, Wilrijk, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - Martin Scheringer
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, 611 37, Czech Republic
| | - Elena Domínguez-Romero
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, 611 37, Czech Republic
| | - Marta Esteban López
- Environmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), 28220, Majadahonda, Spain
| | - Argelia Castaño Calvo
- Environmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), 28220, Majadahonda, Spain
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | |
Collapse
|
4
|
Rodríguez-Carrillo A, Salamanca-Fernández E, den Hond E, Verheyen VJ, Fábelová L, Murinova LP, Pedraza-Díaz S, Castaño A, García-Lario JV, Remy S, Govarts E, Schoeters G, Olea N, Freire C, Fernández MF. Association of exposure to perfluoroalkyl substances (PFAS) and phthalates with thyroid hormones in adolescents from HBM4EU aligned studies. ENVIRONMENTAL RESEARCH 2023; 237:116897. [PMID: 37598845 DOI: 10.1016/j.envres.2023.116897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 07/24/2023] [Accepted: 08/13/2023] [Indexed: 08/22/2023]
Abstract
BACKGROUND Perfluoroalkyl substances (PFAS) and phthalates are synthetic chemicals widely used in various types of consumer products. There is epidemiological and experimental evidence that PFAS and phthalates may alter thyroid hormone levels; however, studies in children and adolescents are limited. AIM To investigate the association of exposure to PFAS and phthalate with serum levels of thyroid hormones in European adolescents. METHODS A cross-sectional study was conducted in 406 female and 327 male adolescents (14-17 years) from Belgium, Slovakia, and Spain participating in the Aligned Studies of the HBM4EU Project (FLEHS IV, PCB cohort, and BEA, respectively). Concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorononanoic acid (PFNA), free thyroxine (FT4), free triiodothyronine (FT3), and thyroid-stimulating hormone (TSH) were measured in sera from study participants, and urinary metabolites of six phthalates (DEP, DiBP, DnBP, BBzP, DEHP, and DiNP) and the non-phthalate plasticizer DINCH® were quantified in spot urine samples. Associations were assessed with linear regression and g-computational models for mixtures. Effect modification by sex was examined. RESULTS In females, serum PFOA and the PFAS mixture concentrations were associated with lower FT4 and higher FT3 levels; MEP and the sums of DEHP, DiNP, and DINCH® metabolites (∑DEHP, ∑DiNP, and ∑DINCH) were associated with higher FT4; ∑DEHP with lower FT3; and the phthalate/DINCH® metabolite mixture with higher FT4 and lower FT3. In males, PFOA was associated with lower FT4 and the PFAS mixture with higher TSH levels and lower FT4/TSH ratio; MEP and ∑DiNP were associated with higher FT4; and MBzP, ∑DEHP, and the phthalate/DINCH® metabolite mixture with lower TSH and higher FT4/TSH. PFOA, mono-(2-ethyl-5-hydroxyhexyl) phthalate (OH-MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (oxo-MEHP), and monocarboxyoctyl phthalate (MCOP) made the greatest contribution to the mixture effect. CONCLUSIONS Results suggest that exposure to PFAS and phthalates is associated with sex-specific differences in thyroid hormone levels in adolescents.
Collapse
Affiliation(s)
- Andrea Rodríguez-Carrillo
- VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium; Toxicological Centre, University of Antwerp, Universiteitsplein, 1, 2610, Wilrijk, Belgium
| | - Elena Salamanca-Fernández
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, University of Granada, 18071, Granada, Spain; Biomedical Research Centre, University of Granada, 18016, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
| | | | - Veerle J Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium
| | - Lucia Fábelová
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia
| | - Lubica Palkovicova Murinova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia
| | - Susana Pedraza-Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Sylvie Remy
- VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400, Mol, Belgium
| | - Greet Schoeters
- Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
| | - Nicolás Olea
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, University of Granada, 18071, Granada, Spain; Biomedical Research Centre, University of Granada, 18016, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
| | - Carmen Freire
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Biomedical Research Centre, University of Granada, 18016, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain; Department of Legal Medicine, Toxicology and Physical Anthropology, University of Granada, 18071, Granada, Spain.
| | - Mariana F Fernández
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain; Department of Radiology and Physical Medicine, University of Granada, 18071, Granada, Spain; Biomedical Research Centre, University of Granada, 18016, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
| |
Collapse
|
5
|
Rodriguez Martin L, Gilles L, Helte E, Åkesson A, Tägt J, Covaci A, Sakhi AK, Van Nieuwenhuyse A, Katsonouri A, Andersson AM, Gutleb AC, Janasik B, Appenzeller B, Gabriel C, Thomsen C, Mazej D, Sarigiannis D, Anastasi E, Barbone F, Tolonen H, Frederiksen H, Klanova J, Koponen J, Tratnik JS, Pack K, Gudrun K, Ólafsdóttir K, Knudsen LE, Rambaud L, Strumylaite L, Murinova LP, Fabelova L, Riou M, Berglund M, Szabados M, Imboden M, Laeremans M, Eštóková M, Janev Holcer N, Probst-Hensch N, Vodrazkova N, Vogel N, Piler P, Schmidt P, Lange R, Namorado S, Kozepesy S, Szigeti T, Halldorsson TI, Weber T, Jensen TK, Rosolen V, Puklova V, Wasowicz W, Sepai O, Stewart L, Kolossa-Gehring M, Esteban-López M, Castaño A, Bessems J, Schoeters G, Govarts E. Time Patterns in Internal Human Exposure Data to Bisphenols, Phthalates, DINCH, Organophosphate Flame Retardants, Cadmium and Polyaromatic Hydrocarbons in Europe. TOXICS 2023; 11:819. [PMID: 37888670 PMCID: PMC10610666 DOI: 10.3390/toxics11100819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 09/21/2023] [Accepted: 09/26/2023] [Indexed: 10/28/2023]
Abstract
Human biomonitoring (HBM) data in Europe are often fragmented and collected in different EU countries and sampling periods. Exposure levels for children and adult women in Europe were evaluated over time. For the period 2000-2010, literature and aggregated data were collected in a harmonized way across studies. Between 2011-2012, biobanked samples from the DEMOCOPHES project were used. For 2014-2021, HBM data were generated within the HBM4EU Aligned Studies. Time patterns on internal exposure were evaluated visually and statistically using the 50th and 90th percentiles (P50/P90) for phthalates/DINCH and organophosphorus flame retardants (OPFRs) in children (5-12 years), and cadmium, bisphenols and polycyclic aromatic hydrocarbons (PAHs) in women (24-52 years). Restricted phthalate metabolites show decreasing patterns for children. Phthalate substitute, DINCH, shows a non-significant increasing pattern. For OPFRs, no trends were statistically significant. For women, BPA shows a clear decreasing pattern, while substitutes BPF and BPS show an increasing pattern coinciding with the BPA restrictions introduced. No clear patterns are observed for PAHs or cadmium. Although the causal relations were not studied as such, exposure levels to chemicals restricted at EU level visually decreased, while the levels for some of their substitutes increased. The results support policy efficacy monitoring and the policy-supportive role played by HBM.
Collapse
Affiliation(s)
- Laura Rodriguez Martin
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Emilie Helte
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Jonas Tägt
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Adrian Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium;
| | - Amrit K. Sakhi
- Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.K.S.); (C.T.)
| | - An Van Nieuwenhuyse
- Laboratoire National de Santé (LNS), Rue Louis Rech 1, 3555 Dudelange, Luxembourg;
| | | | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
- International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), University of Copenhagen, Rigshospitalet, 2100 Copenhagen, Denmark
| | - Arno C. Gutleb
- Luxembourg Institute of Science and Technology (LIST), 4362 Esch-sur-Alzette, Luxembourg;
| | - Beata Janasik
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland; (B.J.); (W.W.)
| | | | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.G.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
| | - Cathrine Thomsen
- Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.K.S.); (C.T.)
| | - Darja Mazej
- Jožef Stefan Institute, 1000 Ljubljana, Slovenia; (D.M.); (J.S.T.)
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.G.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
- Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto–Piazza Della Vittoria 15, 27100 Pavia, Italy
| | - Elena Anastasi
- State General Laboratory, Ministry of Health, 2081 Nicosia, Cyprus; (A.K.); (E.A.)
| | - Fabio Barbone
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy;
| | - Hanna Tolonen
- Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland; (H.T.); (J.K.)
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
| | - Jana Klanova
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 625 00 Brno, Czech Republic; (J.K.); (P.P.)
| | - Jani Koponen
- Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland; (H.T.); (J.K.)
| | | | - Kim Pack
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Koppen Gudrun
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Kristin Ólafsdóttir
- Faculty of Food Science and Nutrition, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland; (K.Ó.); (T.I.H.)
| | - Lisbeth E. Knudsen
- Section of Environmental Health, University of Copenhagen, 1165 Copenhagen, Denmark;
| | - Loïc Rambaud
- Department of Environmental and Occupational Health, Santé Publique France, 94410 Saint Maurice, France (M.R.)
| | - Loreta Strumylaite
- Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania;
| | - Lubica Palkovicova Murinova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 833 03 Bratislava, Slovakia; (L.P.M.)
| | - Lucia Fabelova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 833 03 Bratislava, Slovakia; (L.P.M.)
| | - Margaux Riou
- Department of Environmental and Occupational Health, Santé Publique France, 94410 Saint Maurice, France (M.R.)
| | - Marika Berglund
- Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden; (E.H.); (A.Å.); (J.T.); (M.B.)
| | - Maté Szabados
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Medea Imboden
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland; (M.I.); (N.P.-H.)
| | - Michelle Laeremans
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Milada Eštóková
- Department of Environment and Health, Public Health Authority, 83105 Bratislava, Slovakia;
| | - Natasa Janev Holcer
- Division for Environmental Health, Croatian Institute of Public Health, Rockefellerova 7, 10000 Zagreb, Croatia;
- Department of Social Medicine and Epidemiology, Faculty of Medicine, University of Rijeka, Bráce Branchetta 20/1, 51000 Rijeka, Croatia
| | - Nicole Probst-Hensch
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland; (M.I.); (N.P.-H.)
| | - Nicole Vodrazkova
- Centre for Health and Environment, National Institute of Public Health, 100 00 Prague, Czech Republic; (N.V.); (V.P.)
| | - Nina Vogel
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Pavel Piler
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 625 00 Brno, Czech Republic; (J.K.); (P.P.)
| | - Phillipp Schmidt
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Rosa Lange
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Sónia Namorado
- Department of Epidemiology, National Institute of Health Doctor Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisbon, Portugal;
| | - Szilvia Kozepesy
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Tamás Szigeti
- National Public Health Center, Albert Florian 2-6, 1097 Budapest, Hungary; (M.S.); (S.K.); (T.S.)
| | - Thorhallur I. Halldorsson
- Faculty of Food Science and Nutrition, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland; (K.Ó.); (T.I.H.)
| | - Till Weber
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Tina Kold Jensen
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, 5000 Odense, Denmark;
| | - Valentina Rosolen
- Central Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa di Risparmio 10, 34121 Trieste, Italy;
| | - Vladimira Puklova
- Centre for Health and Environment, National Institute of Public Health, 100 00 Prague, Czech Republic; (N.V.); (V.P.)
| | - Wojciech Wasowicz
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland; (B.J.); (W.W.)
| | - Ovnair Sepai
- UKHSA UK Health Security Agency, Harwell Science Park, Chilton OX11 0RQ, UK; (O.S.); (L.S.)
| | - Lorraine Stewart
- UKHSA UK Health Security Agency, Harwell Science Park, Chilton OX11 0RQ, UK; (O.S.); (L.S.)
| | - Marike Kolossa-Gehring
- Department of Toxicology, Health-Related Environmental Monitoring, German Environment Agency (UBA), 14195 Berlin, Germany; (K.P.); (N.V.); (P.S.); (R.L.); (T.W.)
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain; (M.E.-L.); (A.C.)
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain; (M.E.-L.); (A.C.)
| | - Jos Bessems
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium;
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (K.G.); (M.L.); (J.B.); (G.S.); (E.G.)
| |
Collapse
|
6
|
Cox B, Wauters N, Rodríguez-Carrillo A, Portengen L, Gerofke A, Kolossa-Gehring M, Lignell S, Lindroos AK, Fabelova L, Murinova LP, Desalegn A, Iszatt N, Schillemans T, Åkesson A, Colles A, Den Hond E, Koppen G, Van Larebeke N, Schoeters G, Govarts E, Remy S. PFAS and Phthalate/DINCH Exposure in Association with Age at Menarche in Teenagers of the HBM4EU Aligned Studies. TOXICS 2023; 11:711. [PMID: 37624216 PMCID: PMC10459167 DOI: 10.3390/toxics11080711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 08/03/2023] [Accepted: 08/09/2023] [Indexed: 08/26/2023]
Abstract
Early puberty has been found to be associated with adverse health outcomes such as metabolic and cardiovascular diseases and hormone-dependent cancers. The decrease in age at menarche observed during the past decades has been linked to an increased exposure to endocrine-disrupting compounds (EDCs). Evidence for the association between PFAS and phthalate exposure and menarche onset, however, is inconsistent. We studied the association between PFAS and phthalate/DINCH exposure and age at menarche using data of 514 teenagers (12 to 18 years) from four aligned studies of the Human Biomonitoring for Europe initiative (HBM4EU): Riksmaten Adolescents 2016-2017 (Sweden), PCB cohort (follow-up; Slovakia), GerES V-sub (Germany), and FLEHS IV (Belgium). PFAS concentrations were measured in blood, and phthalate/DINCH concentrations in urine. We assessed the role of each individual pollutant within the context of the others, by using different multi-pollutant approaches, adjusting for age, age- and sex-standardized body mass index z-score and household educational level. Exposure to di(2-ethylhexyl) phthalate (DEHP), especially mono(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP), was associated with an earlier age at menarche, with estimates per interquartile fold change in 5OH-MEHP ranging from -0.34 to -0.12 years in the different models. Findings from this study indicated associations between age at menarche and some specific EDCs at concentrations detected in the general European population, but due to the study design (menarche onset preceded the chemical measurements), caution is needed in the interpretation of causality.
Collapse
Affiliation(s)
- Bianca Cox
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| | - Natasha Wauters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| | - Andrea Rodríguez-Carrillo
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
- Toxicological Centre, University of Antwerp, Universiteitsplein, 1, 2610 Wilrijk, Belgium
| | - Lützen Portengen
- Institute for Risk Assessment Sciences, Utrecht University, 3584 Utrecht, The Netherlands;
| | - Antje Gerofke
- German Environment Agency, Umweltbundesamt (UBA), 14195 Berlin, Germany; (A.G.); (M.K.-G.)
| | - Marike Kolossa-Gehring
- German Environment Agency, Umweltbundesamt (UBA), 14195 Berlin, Germany; (A.G.); (M.K.-G.)
| | - Sanna Lignell
- Swedish Food Agency, 751 26 Uppsala, Sweden; (S.L.); (A.K.L.)
| | | | - Lucia Fabelova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 831 01 Bratislava, Slovakia; (L.F.); (L.P.M.)
| | - Lubica Palkovicova Murinova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 831 01 Bratislava, Slovakia; (L.F.); (L.P.M.)
| | - Anteneh Desalegn
- Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.D.); (N.I.)
| | - Nina Iszatt
- Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456 Oslo, Norway; (A.D.); (N.I.)
| | - Tessa Schillemans
- Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden; (T.S.); (A.Å.)
| | - Agneta Åkesson
- Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden; (T.S.); (A.Å.)
| | - Ann Colles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| | - Elly Den Hond
- Provincial Institute of Hygiene, Provincial Research Centre for Environment and Health, 2023 Antwerp, Belgium;
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| | - Nicolas Van Larebeke
- Analytical, Environmental and Geo-Chemistry, Vrije Universiteit Brussel, 1050 Brussels, Belgium;
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
- Department of Biomedical Sciences, University of Antwerp, 2000 Antwerp, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| | - Sylvie Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (N.W.); (A.R.-C.); (A.C.); (G.K.); (G.S.); (E.G.); (S.R.)
| |
Collapse
|
7
|
Ketema RM, Kasper-Sonnenberg M, Ait Bamai Y, Miyashita C, Koch HM, Pälmke C, Kishi R, Ikeda A. Exposure Trends to the Non-phthalate Plasticizers DEHTP, DINCH, and DEHA in Children from 2012 to 2017: The Hokkaido Study. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2023; 57:11926-11936. [PMID: 37506071 DOI: 10.1021/acs.est.3c03172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/30/2023]
Abstract
Phthalates owing to their endocrine-disrupting effects are regulated in certain products, leading to their replacement with substitutions such as di-2-ethylhexyl terephthalate (DEHTP), 1,2-cyclohexane dicarboxylic acid di(isononyl) ester (DINCH), and di(2-ethylhexyl) adipate (DEHA). However, information on human exposure to these substitutes, especially in susceptible subpopulations such as children, is limited. Thus, we examined the levels and exposure trends of DEHTP, DINCH, and DEHA metabolites in 7 year-old Japanese school children. In total, 180 urine samples collected from 2012 to 2017 were used to quantify 10 DEHTP, DINCH, and DEHA metabolites via isotope dilution liquid chromatography with tandem mass spectrometry. DEHTP and DINCH metabolites were detected in 95.6 and 92.2% of the children, respectively, and DEHA was not detected. This study, annually conducted between 2012 and 2017, revealed a significant (p < 0.05) 5-fold increase in DEHTP metabolites and a 2-fold increase in DINCH metabolites. However, the maximum estimated internal exposures were still below the health-based guidance and toxicological reference values. Exposure levels to DEHTP and DINCH have increased considerably in Japanese school children. DEHA is less relevant. Future studies are warranted to closely monitor the increasing trend in different aged and larger populations and identify the potential health effects and sources contributing to increasing exposure and intervene if necessary.
Collapse
Affiliation(s)
- Rahel Mesfin Ketema
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Faculty of Health Sciences, Hokkaido University, North 12, West 5, Sapporo 060-0812, Japan
| | - Monika Kasper-Sonnenberg
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Yu Ait Bamai
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Toxicological Center, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium
| | - Chihiro Miyashita
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Claudia Pälmke
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Reiko Kishi
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
| | - Atsuko Ikeda
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Faculty of Health Sciences, Hokkaido University, North 12, West 5, Sapporo 060-0812, Japan
| |
Collapse
|
8
|
Vorkamp K, Esteban López M, Gilles L, Göen T, Govarts E, Hajeb P, Katsonouri A, Knudsen LE, Kolossa-Gehring M, Lindh C, Nübler S, Pedraza-Díaz S, Santonen T, Castaño A. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt. Int J Hyg Environ Health 2023; 251:114183. [PMID: 37148759 DOI: 10.1016/j.ijheh.2023.114183] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/08/2023]
Abstract
The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in HBM4EU, addressing the chemical exposure of the general population, temporal developments, occupational exposure and a public health intervention on mercury in populations with high fish consumption. The analyses covered 15 priority groups of organic chemicals and metals and were carried out by a network of laboratories meeting the requirements of a comprehensive quality assurance and control system. The coordination of the chemical analyses included establishing contacts between sample owners and qualified laboratories and monitoring the progress of the chemical analyses during the analytical phase, also addressing status and consequences of Covid-19 measures. Other challenges were related to the novelty and complexity of HBM4EU, including administrative and financial matters and implementation of standardized procedures. Many individual contacts were necessary in the initial phase of HBM4EU. However, there is a potential to develop more streamlined and standardized communication and coordination in the analytical phase of a consolidated European HBM programme.
Collapse
Affiliation(s)
- Katrin Vorkamp
- Aarhus University, Department of Environmental Science, Roskilde, Denmark.
| | - Marta Esteban López
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Thomas Göen
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Parvaneh Hajeb
- Aarhus University, Department of Environmental Science, Roskilde, Denmark
| | | | - Lisbeth E Knudsen
- University of Copenhagen, Institute of Public Health, Copenhagen, Denmark
| | | | - Christian Lindh
- Lund University, Division of Occupational and Environmental Medicine, Lund, Sweden
| | - Stefanie Nübler
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Susana Pedraza-Díaz
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Helsinki, Finland
| | - Argelia Castaño
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| |
Collapse
|
9
|
Vogel N, Schmidt P, Lange R, Gerofke A, Sakhi AK, Haug LS, Jensen TK, Frederiksen H, Szigeti T, Csákó Z, Murinova LP, Sidlovska M, Janasik B, Wasowicz W, Tratnik JS, Mazej D, Gabriel C, Karakitsios S, Barbone F, Rosolen V, Rambaud L, Riou M, Murawski A, Leseman D, Koppen G, Covaci A, Lignell S, Lindroos AK, Zvonar M, Andryskova L, Fabelova L, Richterova D, Horvat M, Kosjek T, Sarigiannis D, Maroulis M, Pedraza-Diaz S, Cañas A, Verheyen VJ, Bastiaensen M, Gilles L, Schoeters G, Esteban-López M, Castaño A, Govarts E, Koch HM, Kolossa-Gehring M. Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021. Int J Hyg Environ Health 2023; 249:114101. [PMID: 36805185 DOI: 10.1016/j.ijheh.2022.114101] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 12/02/2022] [Accepted: 12/08/2022] [Indexed: 02/19/2023]
Abstract
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Collapse
Affiliation(s)
- Nina Vogel
- German Environment Agency (UBA), Berlin, Germany.
| | | | - Rosa Lange
- German Environment Agency (UBA), Berlin, Germany
| | | | | | - Line S Haug
- Norwegian Institute of Public Health, Oslo, Norway
| | - Tina Kold Jensen
- IST - Clinical Pharmacology, Pharmacy and Environmental Medicine, Odense, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
| | | | - Zsófia Csákó
- National Public Health Center, Budapest, Hungary
| | | | | | - Beata Janasik
- Nofer Institute of Occupational Medicine, Lodz, Poland
| | | | - Janja Snoj Tratnik
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Darja Mazej
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Fabio Barbone
- Department of Medicine-DAME, University of Udine, Udine, Italy
| | - Valentina Rosolen
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy
| | - Loïc Rambaud
- Santé publique France, Environmental and Occupational Health Division, Saint-Maurice, France
| | - Margaux Riou
- Santé publique France, Environmental and Occupational Health Division, Saint-Maurice, France
| | | | - Daan Leseman
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Adrian Covaci
- Toxicological Center, University of Antwerp, Wilrijk, Belgium
| | | | | | - Martin Zvonar
- RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
| | - Lenka Andryskova
- RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
| | - Lucia Fabelova
- Slovak Medical University, Faculty of Public Health, Bratislava, Slovakia
| | - Denisa Richterova
- Slovak Medical University, Faculty of Public Health, Bratislava, Slovakia
| | - Milena Horvat
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Tina Kosjek
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece; Environmental Health Engineering, Institute of Advanced Study, Pavia, Italy
| | - Marios Maroulis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Susana Pedraza-Diaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Ana Cañas
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Veerle J Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | | | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences and Toxicological Centre, Antwerp, Belgium
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany
| | | |
Collapse
|
10
|
Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021). Int J Hyg Environ Health 2023; 249:114119. [PMID: 36773580 DOI: 10.1016/j.ijheh.2023.114119] [Citation(s) in RCA: 30] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 12/19/2022] [Accepted: 01/24/2023] [Indexed: 02/11/2023]
Abstract
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures.
Collapse
|
11
|
Vogel N, Lange R, Schmidt P, Rodriguez Martin L, Remy S, Springer A, Puklová V, Černá M, Rudnai P, Középesy S, Janasik B, Ligocka D, Fábelová L, Kolena B, Petrovicova I, Jajcaj M, Eštóková M, Esteban-Lopez M, Castaño A, Tratnik JS, Stajnko A, Knudsen LE, Toppari J, Main KM, Juul A, Andersson AM, Jørgensen N, Frederiksen H, Thomsen C, Sakhi AK, Åkesson A, Hartmann C, Dewolf MC, Koppen G, Biot P, Den Hond E, Voorspoels S, Gilles L, Govarts E, Murawski A, Gerofke A, Weber T, Rüther M, Gutleb AC, Guignard C, Berman T, Koch HM, Kolossa-Gehring M. Exposure to Phthalates in European Children, Adolescents and Adults since 2005: A Harmonized Approach Based on Existing HBM Data in the HBM4EU Initiative. TOXICS 2023; 11:241. [PMID: 36977006 PMCID: PMC10057641 DOI: 10.3390/toxics11030241] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 02/10/2023] [Accepted: 02/14/2023] [Indexed: 06/18/2023]
Abstract
Phthalates are mainly used as plasticizers and are associated inter alia with adverse effects on reproductive functions. While more and more national programs in Europe have started monitoring internal exposure to phthalates and its substitute 1,2-Cyclohexanedicarboxylic acid (DINCH), the comparability of results from such existing human biomonitoring (HBM) studies across Europe is challenging. They differ widely in time periods, study samples, degree of geographical coverage, design, analytical methodology, biomarker selection, and analytical quality assurance level. The HBM4EU initiative has gathered existing HBM data of 29 studies from participating countries, covering all European regions and Israel. The data were prepared and aggregated by a harmonized procedure with the aim to describe-as comparably as possible-the EU-wide general population's internal exposure to phthalates from the years 2005 to 2019. Most data were available from Northern (up to 6 studies and up to 13 time points), Western (11; 19), and Eastern Europe (9; 12), e.g., allowing for the investigation of time patterns. While the bandwidth of exposure was generally similar, we still observed regional differences for Butyl benzyl phthalate (BBzP), Di(2-ethylhexyl) phthalate (DEHP), Di-isononyl phthalate (DiNP), and Di-isobutyl phthalate (DiBP) with pronounced decreases over time in Northern and Western Europe, and to a lesser degree in Eastern Europe. Differences between age groups were visible for Di-n-butyl phthalate (DnBP), where children (3 to 5-year olds and 6 to 11-year olds) had lower urinary concentrations than adolescents (12 to 19-year-olds), who in turn had lower urinary concentrations than adults (20 to 39-year-olds). This study is a step towards making internal exposures to phthalates comparable across countries, although standardized data were not available, targeting European data sets harmonized with respect to data formatting and calculation of aggregated data (such as developed within HBM4EU), and highlights further suggestions for improved harmonization in future studies.
Collapse
Affiliation(s)
- Nina Vogel
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Rosa Lange
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | | | - Sylvie Remy
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Andrea Springer
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Vladimíra Puklová
- National Institute of Public Health, Centre for Health and Environment, 10000 Prague, Czech Republic
| | - Milena Černá
- National Institute of Public Health, Centre for Health and Environment, 10000 Prague, Czech Republic
| | - Péter Rudnai
- National Public Health Center, Environmental Health Unit of the Department of Public Health Laboratory, 1097 Budapest, Hungary
| | - Szilvia Középesy
- National Public Health Center, Environmental Health Unit of the Department of Public Health Laboratory, 1097 Budapest, Hungary
| | - Beata Janasik
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland
| | - Danuta Ligocka
- Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland
| | - Lucia Fábelová
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Branislav Kolena
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 94901 Nitra, Slovakia
| | - Ida Petrovicova
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 94901 Nitra, Slovakia
| | - Michal Jajcaj
- Public Health Authority, Department of Environment and Health, 83105 Bratislava, Slovakia
| | - Milada Eštóková
- Public Health Authority, Department of Environment and Health, 83105 Bratislava, Slovakia
| | | | | | - Janja Snoj Tratnik
- Department of Environmental Sciences, Jožef Stefan Institute, Jamova Cesta 39, 1000 Ljubljana, Slovenia
| | - Anja Stajnko
- Department of Environmental Sciences, Jožef Stefan Institute, Jamova Cesta 39, 1000 Ljubljana, Slovenia
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen, 1165 Copenhagen, Denmark
| | - Jorma Toppari
- Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, 20520 Turku, Finland
- Department of Pediatrics, Turku University Hospital, 20521 Turku, Finland
| | - Katharina M. Main
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
| | - Anders Juul
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
| | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Niels Jørgensen
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
| | - Cathrine Thomsen
- Department of Food Safety, Norwegian Institute of Public Health, 0456 Oslo, Norway
| | - Amrit Kaur Sakhi
- Department of Food Safety, Norwegian Institute of Public Health, 0456 Oslo, Norway
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
| | | | | | - Gudrun Koppen
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, 1060 Brussels, Belgium
| | - Elly Den Hond
- Department of Environment and Health, Provincial Institute of Hygiene (PIH), 2000 Antwerp, Belgium
| | - Stefan Voorspoels
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Liese Gilles
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Eva Govarts
- Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Aline Murawski
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Antje Gerofke
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Till Weber
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Maria Rüther
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| | - Arno C. Gutleb
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology, L-4422 Belvaux, Luxembourg
| | - Cedric Guignard
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology, L-4422 Belvaux, Luxembourg
| | - Tamar Berman
- Department of Environmental Health, Ministry of Health, Jerusalem 9446724, Israel
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance—Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany
| | - Marike Kolossa-Gehring
- German Environment Agency (UBA), Department of Toxicology, Health-Related Environmental Monitoring, 14195 Berlin, Germany
| |
Collapse
|
12
|
Gerofke A, David M, Schmidt P, Vicente JL, Buekers J, Gilles L, Colles A, Bessems J, Bastiaensen M, Covaci A, Den Hond E, Koppen G, Laeremans M, Verheyen VJ, Černá M, Klánová J, Krsková A, Zvonař M, Knudsen LE, Koch HM, Jensen TK, Rambaud L, Riou M, Vogel N, Gabriel C, Karakitsios S, Papaioannou N, Sarigiannis D, Kakucs R, Középesy S, Rudnai P, Szigeti T, Barbone F, Rosolen V, Guignard C, Gutleb AC, Sakhi AK, Haug LS, Janasik B, Ligocka D, Estokova M, Fabelova L, Kolena B, Murinova LP, Petrovicova I, Richterova D, Horvat M, Mazej D, Tratnik JS, Runkel AA, Castaño A, Esteban-López M, Pedraza-Díaz S, Åkesson A, Lignell S, Vlaanderen J, Zock JP, Schoeters G, Kolossa-Gehring M. From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure. Int J Hyg Environ Health 2023; 247:114073. [PMID: 36434900 PMCID: PMC9758616 DOI: 10.1016/j.ijheh.2022.114073] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 10/19/2022] [Accepted: 11/07/2022] [Indexed: 11/25/2022]
Abstract
Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.
Collapse
Affiliation(s)
- Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany,Corresponding author.
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Joana Lobo Vicente
- European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen, Denmark
| | - Jurgen Buekers
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Liese Gilles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Ann Colles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Jos Bessems
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | | - Adrian Covaci
- Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium
| | | | - Gudrun Koppen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Michelle Laeremans
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Veerle J. Verheyen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Milena Černá
- National Institute of Public Health, Prague, Czech Republic
| | - Jana Klánová
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Andrea Krsková
- National Institute of Public Health, Prague, Czech Republic
| | - Martin Zvonař
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic,Faculty of Sport Studies, Masaryk University, Kamenice 753/5, Brno, Czech Republic
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen Øster Farimagsgade 5 DK Copenhagen, Denmark
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance − Institute of the Ruhr University Bochum (IPA), 44789, Bochum, Germany
| | - Tina Kold Jensen
- Faculty of Health Sciences, Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - Loïc Rambaud
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Margaux Riou
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Nina Vogel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Nafsika Papaioannou
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece,Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto - Piazza Della Vittoria 15, 27100, Pavia, Italy
| | - Réka Kakucs
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Szilvia Középesy
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Péter Rudnai
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Tamás Szigeti
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100, Udine, Italy
| | - Valentina Rosolen
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137, Trieste, Italy
| | - Cedric Guignard
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | - Arno C. Gutleb
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | | | | | - Beata Janasik
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Danuta Ligocka
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Milada Estokova
- Public Health Authority of the Slovak Republic, Trnavska cesta 52, 826 45, Bratislava, Slovakia
| | - Lucia Fabelova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Branislav Kolena
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | | | - Ida Petrovicova
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | - Denisa Richterova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Milena Horvat
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Darja Mazej
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Janja Snoj Tratnik
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Agneta Annika Runkel
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Susana Pedraza-Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Sanna Lignell
- Swedish Food Agency, PO Box 622, SE-751 26, Uppsala, Sweden
| | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - Jan-Paul Zock
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | |
Collapse
|
13
|
Nübler S, Esteban López M, Castaño A, Mol HGJ, Haji-Abbas-Zarrabi K, Schäfer M, Müller J, Hajslova J, Dvorakova D, Antignac JP, Koch HM, Haug LS, Vorkamp K, Göen T. Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs) for human biomonitoring of perfluoroalkyl substances (PFASs) in serum as part of the quality assurance programme under HBM4EU. THE SCIENCE OF THE TOTAL ENVIRONMENT 2022; 847:157481. [PMID: 35868372 DOI: 10.1016/j.scitotenv.2022.157481] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 07/13/2022] [Accepted: 07/14/2022] [Indexed: 06/15/2023]
Abstract
Perfluoroalkyl substances (PFASs) are of very high concern due to their persistence and accumulative behaviour as well as their manifold adverse health effects. Human biomonitoring (HBM) based on the determination of PFASs in serum samples is an adequate and established strategy for exposure and risk assessment of the population. The suspected health risks associated with exposure levels in the general population call for reliable HBM data verified by Quality Assurance and Quality Control (QA/QC) measures. PFASs were among the chemicals selected as priority substances in HBM4EU, a pan-European project to harmonize and advance HBM within 30 European countries. For this purpose, the analytical comparability and accuracy of PFASs-analysing laboratories was assessed in a QA/QC programme comprising Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs). This paper presents the evaluation process and discusses the results of four ICI/EQUAS rounds for the determination of eight perfluoroalkyl carboxylic acids and four perfluoroalkyl sulfonic acids (PFBS, PFHxS, PFHpS, PFOS) in serum. All 21 participating laboratories achieved satisfactory results for at least six of these biomarkers, although low limits of quantification (of about 0.1 μg/L) were required to quantify serum PFAS levels at general population exposure levels. The mean relative standard deviation of the participants' results (study RSDR) significantly improved from 22 % to 13 % over all PFAS biomarkers in the course of the four rounds. This QA/QC programme succeeded in establishing a network of laboratories with high analytical comparability and accuracy for the analysis of PFASs across 12 European countries.
Collapse
Affiliation(s)
- Stefanie Nübler
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestraße 9-11, 91054 Erlangen, Germany
| | - Marta Esteban López
- National Center for Environmental Health, Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km2,2, 28220 Madrid, Spain
| | - Argelia Castaño
- National Center for Environmental Health, Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km2,2, 28220 Madrid, Spain
| | - Hans G J Mol
- Wageningen Food Safety Research, part of Wageningen University and Research, Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands
| | - Karin Haji-Abbas-Zarrabi
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestraße 9-11, 91054 Erlangen, Germany
| | - Moritz Schäfer
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestraße 9-11, 91054 Erlangen, Germany
| | - Johannes Müller
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestraße 9-11, 91054 Erlangen, Germany
| | - Jana Hajslova
- University of Chemistry and Technology Prague, Department of Food Analysis and Nutrition, Technicka 5, 16028 Prague, Czech Republic
| | - Darina Dvorakova
- University of Chemistry and Technology Prague, Department of Food Analysis and Nutrition, Technicka 5, 16028 Prague, Czech Republic
| | | | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany
| | - Line Småstuen Haug
- Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway
| | - Katrin Vorkamp
- Aarhus University, Department of Environmental Science, Frederiksborgvej 399, 4000 Roskilde, Denmark
| | - Thomas Göen
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestraße 9-11, 91054 Erlangen, Germany.
| |
Collapse
|
14
|
Pirard C, Charlier C. Urinary levels of parabens, phthalate metabolites, bisphenol A and plasticizer alternatives in a Belgian population: Time trend or impact of an awareness campaign? ENVIRONMENTAL RESEARCH 2022; 214:113852. [PMID: 35820649 DOI: 10.1016/j.envres.2022.113852] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Revised: 07/04/2022] [Accepted: 07/06/2022] [Indexed: 06/15/2023]
Abstract
A human biomonitoring study was carried out in 2015 within an adult population living in Liege (Belgium). Some phthalate metabolites and parabens were measured in the urine of 252 participants, and information were collected about their food habits, life styles and home environment to identify some predictors of exposure. Concomitantly, an awareness campaign was initiated by the Provincial Authorities of Liege and spread over 2 years. Three years later (2018), 92 of the initial participants provided again urine samples, and the levels of phthalate metabolites, phthalate substitute (DINCH), parabens, bisphenol-A and bisphenol alternatives (bisphenol-S, -F, -Z, -P) were determined and compared to those obtained in 2015 to assess time trends. In 2015, methyl- and ethylparaben were the most abundant parabens (P50 = 9.12 μg/L and 1.1 μg/L respectively), while propyl- and butylparaben were sparsely detected. Except for mono-2-ethylhexyl phthalate and 6-OH-mono-propyl-heptyl phthalate, all other targeted phthalate metabolites were positively quantified in most of the urine samples (between 89 and 98%) with median concentrations ranging between 2.7 μg/L and 21.3 μg/L depending on the metabolite. The multivariate regression models highlighted some significant associations between urinary phthalate metabolite or paraben levels and age, rural or urban character of the residence place, and the use of some personal care products. However, all determination coefficients were weak meaning that the usual covariates included in the models only explained a small part of the variance. Between 2015 and 2018, levels of parabens and phthalate metabolites significantly decreased (from 1.3 to 2.5 fold) except for monoethyl phthalate which seemed to remain quite constant. Contrariwise, all bisphenol alternatives and DINCH metabolites were measured in higher concentrations in 2018 vs 2015 while BPA levels did not differ significantly. However, it was not feasible to unequivocally highlight an impact of the awareness campaign on the exposure levels of the population.
Collapse
Affiliation(s)
- Catherine Pirard
- Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000, Liege, Belgium; Center for Interdisciplinary Research on Medicines (CIRM), University of Liege (ULiege), CHU (B35), 4000, Liege, Belgium.
| | - Corinne Charlier
- Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000, Liege, Belgium; Center for Interdisciplinary Research on Medicines (CIRM), University of Liege (ULiege), CHU (B35), 4000, Liege, Belgium
| |
Collapse
|
15
|
Rosolen V, Giordani E, Mariuz M, Parpinel M, Ronfani L, Vecchi Brumatti L, Bin M, Calamandrei G, Mustieles V, Gilles L, Govarts E, Baken K, Rodriguez Martin L, Schoeters G, Sepai O, Sovcikova E, Fabelova L, Šidlovská M, Kolena B, Kold Jensen T, Frederiksen H, Kolossa-Gehring M, Lange R, Apel P, Castano A, Esteban López M, Jacobs G, Voorspoels S, Jurdáková H, Górová R, Barbone F. Concurrent Assessment of Phthalates/HEXAMOLL ® DINCH Exposure and Wechsler Intelligence Scale for Children Performance in Three European Cohorts of the HBM4EU Aligned Studies. TOXICS 2022; 10:538. [PMID: 36136503 PMCID: PMC9502751 DOI: 10.3390/toxics10090538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 08/31/2022] [Accepted: 09/13/2022] [Indexed: 06/16/2023]
Abstract
Information about the effects of phthalates and non-phthalate substitute cyclohexane-1,2-dicarboxylic acid diisononyl ester (HEXAMOLL® DINCH) on children's neurodevelopment is limited. The aim of the present research is to evaluate the association between phthalate/HEXAMOLL® DINCH exposure and child neurodevelopment in three European cohorts involved in HBM4EU Aligned Studies. Participating subjects were school-aged children belonging to the Northern Adriatic cohort II (NAC-II), Italy, Odense Child Cohort (OCC), Denmark, and PCB cohort, Slovakia. In each cohort, children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score (FSIQ) of the Wechsler Intelligence Scale of Children test using three different editions. The children's urine samples, collected for one point in time concurrently with the neurodevelopmental evaluation, were analyzed for several phthalates/HEXAMOLL® DINCH biomarkers. The relation between phthalates/HEXAMOLL® DINCH and FSIQ was explored by applying separate multiple linear regressions in each cohort. The means and standard deviations of FSIQ were 109 ± 11 (NAC-II), 98 ± 12 (OCC), and 81 ± 15 (PCB cohort). In NAC-II, direct associations between FSIQ and DEHP's biomarkers were found: 5OH-MEHP+5oxo-MEHP (β = 2.56; 95% CI 0.58-4.55; N = 270), 5OH-MEHP+5cx-MEPP (β = 2.48; 95% CI 0.47-4.49; N = 270) and 5OH-MEHP (β = 2.58; 95% CI 0.65-4.51; N = 270). On the contrary, in the OCC the relation between DEHP's biomarkers and FSIQ tended to be inverse but imprecise (p-value ≥ 0.10). No associations were found in the PCB cohort. FSIQ was not associated with HEXAMOLL® DINCH in any cohort. In conclusion, these results do not provide evidence of an association between concurrent phthalate/DINCHHEXAMOLLR DINCH exposure and IQ in children.
Collapse
Affiliation(s)
- Valentina Rosolen
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Elisa Giordani
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Marika Mariuz
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Maria Parpinel
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Luca Ronfani
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Liza Vecchi Brumatti
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Maura Bin
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Gemma Calamandrei
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | - Vicente Mustieles
- Center for Biomedical Research, University of Granada, 18011 Granada, Spain
- Instituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health, 28029 Madrid, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Kirsten Baken
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Eva Sovcikova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Lucia Fabelova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Miroslava Šidlovská
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia
| | - Branislav Kolena
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia
| | - Tina Kold Jensen
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, 5000 Odense, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
- International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
| | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany
| | - Argelia Castano
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Griet Jacobs
- Unit Separation and Conversion Technology, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium
| | - Stefan Voorspoels
- Unit Separation and Conversion Technology, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium
| | - Helena Jurdáková
- Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia
| | - Renáta Górová
- Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia
| | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
- Institute of Hygiene and Clinical Epidemiology, Azienda Sanitaria Universitaria Friuli Centrale, Via Colugna 50, 33100 Udine, Italy
| |
Collapse
|
16
|
Phthalate Exposure: From Quantification to Risk Assessment. TOXICS 2022; 10:toxics10060330. [PMID: 35736938 PMCID: PMC9228297 DOI: 10.3390/toxics10060330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 06/14/2022] [Accepted: 06/15/2022] [Indexed: 12/10/2022]
|